Skip to main content

Nutrien Ltd(NTR-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Nutrien Ltd up on Wednesday (NTR)

Automated Summaries - The Globe and Mail - Wed Mar 27, 4:02PM CDT

Today, Nutrien Ltd shares opened at $71.54 and closed at $72.78. Intraday prices ranged from a low of $71.40 to a high of $72.95.

Share prices advanced 0.97% from the previous day's close of $72.08.

During the day across North America, the TSX Composite closed -0.14% at 21912.52, the S&P 500 closed -0.28% at 5203.58, the Dow Jones Industrial Average closed -0.08% at 39282.33 and the Nasdaq Composite closed -0.42% at 16315.70.

Nutrien Ltd has listed on the Toronto Stock Exchange (TSX) under the ticker NTR.

A total of 5,244,495 shares was traded during the last trading day, with total trades of 5,779, with an average volume of 2,260,395 over 5 days.

Trading across the entire TSX saw 3,990 price advancers against 1,258 declines and 113 unchanged.

During the prior 52 weeks, NTR.TO has traded as high as $101.31 (April 03,2023) and low as $64.89 (February 14,2024). Moreover, the shares have shrunken -26.51 percent in the last 52 weeks, while they have eased -2.51% year-to-date.

It announced a 0.54 dividend on February 21/24, with an March 27/24 ex-date and April 11/24 pay day.

Following today's trading, Nutrien Ltd has a market capitalization of $35.65 billion on a float of 494,563 shares outstanding. Its annual EPS is $2.53.

Nutrien Ltd is a TSX Agricultural Inputs company headquartered in Saskatoon, CAN.

Currently, Nutrien Ltd's consensus rating is "Moderate Buy" based on 20 analysts according to Zacks. From those 20 analysts, 13 have buy ratings, 2 have sell ratings and 5 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe